NLRP3 and preeclampsia: Despite many unknowns in the pathomechanism of PE development studies proving the crucial role of NLRP3 in that process and delineating DAMPs, which can activate the inflammasome can be a source of great change in the therapy and prophylaxis of preeclampsia.